Skip to main content
Top
Published in: BMC Medical Imaging 1/2020

Open Access 01-12-2020 | Positron Emission Tomography | Research article

Assessing and reducing PET radiotracer infiltration rates: a single center experience in injection quality monitoring methods and quality improvement

Authors: Dustin R. Osborne, Shelley N. Acuff, Michael Fang, Melissa D. Weaver, Yitong Fu

Published in: BMC Medical Imaging | Issue 1/2020

Login to get access

Abstract

Background

Successful injection of radiolabeled compounds is critical for positron emission tomography (PET) imaging. A poor quality injection limits the tracer availability in the body and can impact diagnostic results. In this study, we attempt to quantify our infiltration rates, develop an actionable quality improvement plan to reduce potentially compromised injections, and compare injection scoring to PET/CT imaging results.

Methods

A commercially available system that uses external radiation detectors was used to monitor and score injection quality. This system compares the time activity curves of the bolus relative to a control reading in order to provide a score related to the quality of the injection. These injection scores were used to assess infiltration rates at our facility in order to develop and implement a quality improvement plan for our PET imaging center. Injection scores and PET imaging results were reviewed to determine correlations between image-based assessments of infiltration, such as liver SUVs, and injection scoring, as well as to gather infiltration reporting statistics by physicians.

Results

A total of 1033 injections were monitored at our center. The phase 1 infiltration rate was 2.1%. In decision tree analysis, patients < 132.5lbs were associated with infiltrations. Additional analyses suggested patients > 127.5 lbs. with non-antecubital injections were associated with lower quality injections. Our phase 2 infiltration rate was 1.9%. Comparison of injection score to SUV showed no significant correlation and indicated that only 63% of suspected infiltrations were visible on PET/CT imaging.

Conclusions

Developing a quality improvement plan and monitoring PET injections can lead to reduced infiltration rates. No significant correlation between reference SUVs and injection score provides evidence that determination of infiltration based on PET images alone may be limited. Results also indicate that the number of infiltrated PET injections is under-reported.
Literature
1.
go back to reference Osman MM, et al. FDG dose extravasations in PET/CT: frequency and impact on SUV measurements. Front Oncol. 2011;1. Osman MM, et al. FDG dose extravasations in PET/CT: frequency and impact on SUV measurements. Front Oncol. 2011;1.
2.
go back to reference Watson CC, et al. Optimizing injected dose in clinical PET by accurately modeling the counting-rate response functions specific to individual patient scans. J Nucl Med. 2005;46(11):1825–34.PubMed Watson CC, et al. Optimizing injected dose in clinical PET by accurately modeling the counting-rate response functions specific to individual patient scans. J Nucl Med. 2005;46(11):1825–34.PubMed
3.
go back to reference Hung JC. Comparison of various requirements of the quality assurance procedures for 18F-FDG injection*. J Nucl Med. 2002;43(11):1495–506.PubMed Hung JC. Comparison of various requirements of the quality assurance procedures for 18F-FDG injection*. J Nucl Med. 2002;43(11):1495–506.PubMed
4.
go back to reference Schmitt M, et al. Different techniques of administering FDG for clinical PET imaging. J Nucl Med. 2012;53(supplement 1):2609. Schmitt M, et al. Different techniques of administering FDG for clinical PET imaging. J Nucl Med. 2012;53(supplement 1):2609.
5.
go back to reference Plaxton N, et al. Factors that influence standard uptake values in FDG PET/CT. J Nucl Med. 2014;55(supplement 1):1356. Plaxton N, et al. Factors that influence standard uptake values in FDG PET/CT. J Nucl Med. 2014;55(supplement 1):1356.
6.
go back to reference Ziai P, et al. Role of optimal quantification of FDG PET imaging in the clinical practice of radiology. RadioGraphics. 2016;36(2):481–96.CrossRefPubMed Ziai P, et al. Role of optimal quantification of FDG PET imaging in the clinical practice of radiology. RadioGraphics. 2016;36(2):481–96.CrossRefPubMed
7.
go back to reference Kiser JW, et al. Impact of an 18F-FDG PET/CT radiotracer injection infiltration on patient management-a case report. Front Med (Lausanne). 2018;5:143.CrossRef Kiser JW, et al. Impact of an 18F-FDG PET/CT radiotracer injection infiltration on patient management-a case report. Front Med (Lausanne). 2018;5:143.CrossRef
8.
go back to reference Townsend D, et al. Multi-Center Assessment of Infiltration Rates in FDG-PET/CT scans: Detection, Incidence, and Contributing Factors. J Nucl Med. 2018;59(supplement 1):520. Townsend D, et al. Multi-Center Assessment of Infiltration Rates in FDG-PET/CT scans: Detection, Incidence, and Contributing Factors. J Nucl Med. 2018;59(supplement 1):520.
9.
go back to reference van der Pol J, et al. Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review. Eur J Nucl Med Mol Imaging. 2017;44(7):1234–43.CrossRefPubMedPubMedCentral van der Pol J, et al. Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review. Eur J Nucl Med Mol Imaging. 2017;44(7):1234–43.CrossRefPubMedPubMedCentral
10.
go back to reference Kinahan PE, Fletcher JW. PET/CT standardized uptake values (SUVs) in clinical practice and assessing response to therapy. Semin Ultrasound CT MR. 2010;31(6):496–505.CrossRefPubMedPubMedCentral Kinahan PE, Fletcher JW. PET/CT standardized uptake values (SUVs) in clinical practice and assessing response to therapy. Semin Ultrasound CT MR. 2010;31(6):496–505.CrossRefPubMedPubMedCentral
11.
go back to reference Park J, et al. Tumor SUVmax normalized to liver uptake on (18) F-FDG PET/CT predicts the pathologic complete response after Neoadjuvant Chemoradiotherapy in locally advanced rectal Cancer. Nucl Med Mol Imaging. 2014;48(4):295–302.CrossRefPubMedPubMedCentral Park J, et al. Tumor SUVmax normalized to liver uptake on (18) F-FDG PET/CT predicts the pathologic complete response after Neoadjuvant Chemoradiotherapy in locally advanced rectal Cancer. Nucl Med Mol Imaging. 2014;48(4):295–302.CrossRefPubMedPubMedCentral
12.
go back to reference Keramida G, et al. Quantification of tumour (18) F-FDG uptake: normalise to blood glucose or scale to liver uptake? Eur Radiol. 2015;25(9):2701–8.CrossRefPubMed Keramida G, et al. Quantification of tumour (18) F-FDG uptake: normalise to blood glucose or scale to liver uptake? Eur Radiol. 2015;25(9):2701–8.CrossRefPubMed
13.
go back to reference Liu G, et al. Variations of the liver standardized uptake value in relation to background blood metabolism: an 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography study in a large population from China. Medicine. 2018;97(19):e0699.CrossRefPubMedPubMedCentral Liu G, et al. Variations of the liver standardized uptake value in relation to background blood metabolism: an 2-[18F]Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography study in a large population from China. Medicine. 2018;97(19):e0699.CrossRefPubMedPubMedCentral
14.
go back to reference Shih W-J, et al. Axillary lymph node uptake of Tc-99m MIBI resulting from extravasation should not be misinterpretated as metastasis. Ann Nucl Med. 1999;13(4):269–71.CrossRefPubMed Shih W-J, et al. Axillary lymph node uptake of Tc-99m MIBI resulting from extravasation should not be misinterpretated as metastasis. Ann Nucl Med. 1999;13(4):269–71.CrossRefPubMed
15.
go back to reference Lattanze RK, et al. Usefulness of Topically Applied Sensors to Assess the Quality of 18F-FDG Injections and Validation Against Dynamic Positron Emission Tomography (PET) Images. Frontiers in Medicine. 2018;5:303.CrossRefPubMedPubMedCentral Lattanze RK, et al. Usefulness of Topically Applied Sensors to Assess the Quality of 18F-FDG Injections and Validation Against Dynamic Positron Emission Tomography (PET) Images. Frontiers in Medicine. 2018;5:303.CrossRefPubMedPubMedCentral
16.
go back to reference Wong TZ, et al. Findings from quality improvement initiatives to assess and improve PET/CT FDG injection infiltration rates in multiple centers. Journal of Nuclear Medicine Technology. 2019. Wong TZ, et al. Findings from quality improvement initiatives to assess and improve PET/CT FDG injection infiltration rates in multiple centers. Journal of Nuclear Medicine Technology. 2019.
Metadata
Title
Assessing and reducing PET radiotracer infiltration rates: a single center experience in injection quality monitoring methods and quality improvement
Authors
Dustin R. Osborne
Shelley N. Acuff
Michael Fang
Melissa D. Weaver
Yitong Fu
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Medical Imaging / Issue 1/2020
Electronic ISSN: 1471-2342
DOI
https://doi.org/10.1186/s12880-020-0408-3

Other articles of this Issue 1/2020

BMC Medical Imaging 1/2020 Go to the issue